Cannabinoid receptor type 2
- Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update (27 Feb 2023)
- Endocannabinoid System: Chemical Characteristics and Biological Activity (27 Feb 2023)
- Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review (27 Feb 2023)
- Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance (27 Feb 2023)
- Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies (27 Feb 2023)
- Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance (27 Nov 2022)
- CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis (27 Nov 2022)
- Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells (27 Nov 2022)
- A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications (27 Nov 2022)
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells (05 Sep 2022)
- The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies (05 Sep 2022)
- Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
- New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists (05 Sep 2022)
- Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? (05 Sep 2022)
- Kahweol, a natural diterpene from coffee, induces peripheral antinociception by endocannabinoid system activation (05 Sep 2022)
- CB2 Receptor Involvement in the Treatment of Substance Use Disorders (05 Sep 2022)
- Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells (05 Sep 2022)
- The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders (01 Sep 2022)
- Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells (01 Sep 2022)
- N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors (01 Sep 2022)
- Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
- Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy (01 Sep 2022)
- CB2 Receptor in Microglia: The Guardian of Self-Control (01 Sep 2022)
- The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies (27 Aug 2022)
- Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
- Inhibition of Nociception in a Preclinical Episodic Migraine Model by Dietary Supplementation of Grape Seed Extract Involves Activation of Endocannabinoid Receptors (27 Aug 2022)
- Enhancing Endocannabinoid Control of Stress with Cannabidiol (27 Aug 2022)
- Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases (27 Aug 2022)
- Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment (27 Aug 2022)
- Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review (27 Aug 2022)
- 1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists (27 Aug 2022)
- Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
- In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties (13 Aug 2022)
- Considerations for Cannabinoids in Perioperative Care by Anesthesiologists (13 Aug 2022)
- Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review (13 Aug 2022)
- Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation (13 Aug 2022)
- Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes (13 Aug 2022)
- The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy (07 Aug 2022)
- The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study (07 Aug 2022)
- New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders (07 Aug 2022)
- Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects (07 Aug 2022)
- The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation (05 Aug 2022)
- Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
- Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination (05 Aug 2022)
- Medical Cannabis in Pediatric Oncology: Friend or Foe? (05 Aug 2022)
- Interaction of Glia Cells with Glioblastoma and Melanoma Cells under the Influence of Phytocannabinoids (05 Aug 2022)
- Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures (05 Aug 2022)
- Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders (05 Aug 2022)
- Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option? (05 Aug 2022)
- Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis (05 Aug 2022)
- Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis (05 Aug 2022)
- A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells (05 Aug 2022)
- A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo (05 Aug 2022)
- The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies (31 Jul 2022)
- The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System (31 Jul 2022)
- South African Family Practice (31 Jul 2022)
- Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (31 Jul 2022)
- Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
- Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action (31 Jul 2022)
- Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review (31 Jul 2022)
- In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer (31 Jul 2022)
- Impact of Cannabinoid Compounds on Skin Cancer (31 Jul 2022)
- Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)
- Cannabinoids for the Treatment of Dermatologic Conditions (31 Jul 2022)
- A critical review of cannabis in medicine and dentistry: A look back and the path forward (31 Jul 2022)
- Involvement of the endocannabinoid system in the inhibition of Sindbis virus replication: a preliminary study - Journal of Cannabis Research (26 Jul 2022)
- Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story? - Journal of Cannabis Research (26 Jul 2022)
- CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature - Journal of Cannabis Research (26 Jul 2022)
- Endocannabinoid System and Migraine Pain: An Update (25 Jul 2022)
- ICRS 2019: CBD for Anxiety, Cancer, Heart Disease, Addiction... (21 Jul 2022)
- Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review (21 Jul 2022)
- Endocannabinoid Discovery Timeline (21 Jul 2022)
- Cannabis & the Immune System: A Complex Balancing Act (21 Jul 2022)
- Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (20 Jul 2022)
- The Role of Cannabinoid Receptors (18 Jul 2022)
- Endocannabinoid System (18 Jul 2022)